Skip to content

Chinese Research Group of Gallbladder Cancer

Chinese Research Group of Gallbladder Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04140552
Acronym
CRGGC
Enrollment
10000
Registered
2019-10-28
Start date
2008-01-01
Completion date
2025-12-31
Last updated
2021-06-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder Neoplasms

Keywords

gallbladder neoplasms, gallbladder cancer

Brief summary

The Chinese Research Group of Gallbladder Cancer (CRGGC) is a retrospective multicenter registry cohort, collecting electronic medical records of patients diagnosed with gallbladder cancer from hospitals in collaboration.

Detailed description

The objectives of the CRGGC are as follows: 1. To study the current diagnosis and treatment of gallbladder cancer in China. 2. To clarify the prognostic role of debated risk factors associated with gallbladder cancer. 3. To improve the accurate staging of gallbladder cancer. 4. To standardize the treatment with gallbladder cancer.

Interventions

None listed

Sponsors

The First Affiliated Hospital of Anhui Medical University
CollaboratorOTHER
Anhui Provincial Hospital
CollaboratorOTHER_GOV
The First Affiliated Hospital of Bengbu Medical University
CollaboratorOTHER
LanZhou University
CollaboratorOTHER
Henan Cancer Hospital
CollaboratorOTHER_GOV
The First Affiliated Hospital of Zhengzhou University
CollaboratorOTHER
The Second Affiliated Hospital of Harbin Medical University
CollaboratorOTHER
First Affiliated Hospital of Harbin Medical University
CollaboratorOTHER
Harbin Medical University
CollaboratorOTHER
The First Hospital of Jilin University
CollaboratorOTHER
Second Hospital of Jilin University
CollaboratorOTHER
China-Japan Union Hospital, Jilin University
CollaboratorOTHER
The First People's Hospital of Changzhou
CollaboratorOTHER
Changzhou No.2 People's Hospital
CollaboratorOTHER
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
CollaboratorOTHER
The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China
CollaboratorOTHER
The First People's Hospital of Taicang
CollaboratorUNKNOWN
Wuxi No. 2 People's Hospital
CollaboratorOTHER
Xuzhou Central Hospital
CollaboratorOTHER
Second Affiliated Hospital of Suzhou University
CollaboratorOTHER
Affiliated Hospital of Nantong University
CollaboratorOTHER
The First People's Hospital of Nantong
CollaboratorUNKNOWN
The Affiliated Hospital of Xuzhou Medical University
CollaboratorOTHER
Second Affiliated Hospital of Nanchang University
CollaboratorOTHER
The First Affiliated Hospital of Nanchang University
CollaboratorOTHER
Jiangxi Provincial People's Hopital
CollaboratorOTHER
Shengjing Hospital
CollaboratorOTHER
Baotou Central Hospital
CollaboratorOTHER
Qinghai People's Hospital
CollaboratorOTHER
Changzhi Medical College
CollaboratorOTHER
The First Affiliated Hospital of Shanxi Medical University
CollaboratorOTHER
Shanxi Provincial Cancer Hospital
CollaboratorUNKNOWN
First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
Eastern Hepatobiliary Surgery Hospital
CollaboratorOTHER
Shanghai Fengxian District Central Hospital
CollaboratorOTHER
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
CollaboratorOTHER
Shanghai Zhongshan Hospital
CollaboratorOTHER
Shanghai Pudong Hospital
CollaboratorOTHER
Central Hospital of Minhang District, Shanghai
CollaboratorUNKNOWN
Putuo District People's Hospital of Shanghai
CollaboratorUNKNOWN
Xinhua (Chongming) Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
CollaboratorUNKNOWN
Tianjin Medical University Cancer Hospital
CollaboratorUNKNOWN
First Affiliated Hospital of Xinjiang Medical University
CollaboratorOTHER
First Affiliated Hospital of Kunming Medical University
CollaboratorOTHER
Yinzhou Hospital Affiliated to Medical School of Ningbo University
CollaboratorOTHER
Shaoxing Second Hospital
CollaboratorOTHER
Shaoxing People's Hospital
CollaboratorOTHER
First Affiliated Hospital of Wenzhou Medical University
CollaboratorOTHER
Sir Run Run Shaw Hospital
CollaboratorOTHER
Second Affiliated Hospital, School of Medicine, Zhejiang University
CollaboratorOTHER
Zhejiang Cancer Hospital
CollaboratorOTHER
Huizhou Municipal Central Hospital
CollaboratorOTHER
Ningbo No. 1 Hospital
CollaboratorOTHER
People's Hospital of Hunan Province
CollaboratorUNKNOWN
Hainan People's Hospital
CollaboratorOTHER
Taizhou Hospital
CollaboratorOTHER
Xinghua City People's Hospital
CollaboratorUNKNOWN
Tongliao City Hospital
CollaboratorUNKNOWN
Jiangxi Provincial Cancer Hospital
CollaboratorOTHER
Shandong Provincial Hospital
CollaboratorOTHER_GOV
Qilu Hospital of Shandong University
CollaboratorOTHER
The Affiliated Hospital of Qingdao University
CollaboratorOTHER
Xijing Hospital
CollaboratorOTHER
Shanghai Jiao Tong University School of Medicine
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Patients with at least clinical diagnosis of gallbladder cancer, including C23.9 and part of C24.0 (cystic duct cancer). * Patients with accessible electronic medical record

Exclusion criteria

* Patients with undetermined primary site of cancer.

Design outcomes

Primary

MeasureTime frameDescription
Overall Survival5 yearsThe overall survival data were defined by (date of death) - (date of first diagnosis). The survival status of patients were retrieved from follow-up.

Countries

China

Contacts

Primary ContactYingbin Liu, MD, PhD
laoniulyb@163.com+8613918803900

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 16, 2026